Bespoke Extracts Inc (BSPK)
0.0981
-0.01
(-10.78%)
USD |
OTCM |
May 03, 16:00
Bespoke Extracts Debt to Equity Ratio: -0.5235 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2023 | -0.5235 |
| September 30, 2023 | -0.566 |
| June 30, 2023 | -0.6594 |
| March 31, 2023 | -0.7137 |
| December 31, 2022 | -0.6182 |
| September 30, 2022 | -0.42 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.00 |
| November 30, 2021 | -0.3136 |
| August 31, 2021 | -1.197 |
| May 31, 2021 | -1.857 |
| Date | Value |
|---|---|
| February 28, 2021 | 16.65 |
| November 30, 2020 | -1.642 |
| August 31, 2020 | -1.207 |
| May 31, 2020 | -1.019 |
| February 29, 2020 | -1.022 |
| November 30, 2019 | -0.6014 |
| August 31, 2019 | 0.00 |
| May 31, 2019 | 0.0004 |
| February 28, 2019 | -1.093 |
| November 30, 2018 | -1.221 |
| August 31, 2018 | -1.268 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-1.857
Minimum
May 2021
16.65
Maximum
Feb 2021
0.2259
Average
-0.6014
Median
Nov 2019
Debt to Equity Ratio Benchmarks
| NovaBay Pharmaceuticals Inc | 0.3431 |
| Palatin Technologies Inc | 0.00 |
| iBio Inc | -- |
| Theriva Biologics Inc | -- |
| Oragenics Inc | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 0.3544M |
| Total Liabilities (Quarterly) | 2.079M |
| Shareholders Equity (Quarterly) | -1.725M |
| Current Ratio | 0.0759 |
| Net Debt Paydown Yield | -41.16% |